AGREEMENTSchedule 13d Agreement • August 15th, 2006 • Baker Julian • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.001 par value, of Seattle Genetics, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • September 19th, 2024 • General Catalyst Group Management Holdings GP, LLC • Services-computer integrated systems design
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Samsara, Inc.
AGREEMENTSchedule 13d Agreement • March 18th, 2015 • Marcato Capital Management Lp • Services-membership sports & recreation clubs
The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Issuer named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
AGREEMENTSchedule 13d Agreement • May 16th, 2013 • Baker Julian • Services-medical laboratories
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.0001 par value, of Genomic Health, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • November 22nd, 2013 • Lewis Susan Cunningham • Wholesale-petroleum & petroleum products (no bulk stations)
This Agreement was executed by Richard B. Abshire on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which is attached as Exhibit 99.2
AGREEMENTSchedule 13d Agreement • July 5th, 2018 • Frazier Life Sciences VIII, L.P. • Pharmaceutical preparations
This Schedule 13D was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.
AGREEMENTSchedule 13d Agreement • January 2nd, 2009 • Helicos Biosciences Corp • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, each of the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Helicos Biosciences Corporation. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.
AGREEMENTSchedule 13d Agreement • June 3rd, 2013 • Baker Julian • Services-medical laboratories
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.0001 par value, of Genomic Health, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • August 11th, 2022 • Frazier Life Sciences IX, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Phathom Pharmaceuticals, Inc.
AGREEMENTSchedule 13d Agreement • October 9th, 2012 • Alcatel Lucent • Telephone & telegraph apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of CollabRx, Inc.
AGREEMENTSchedule 13d Agreement • May 18th, 2012 • Baker Julian • Services-medical laboratories
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.0001 par value, of Genomic Health, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • September 23rd, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need to be filed with respect to the ownership by each of the undersigned of shares of Common Stock of MBX Biosciences, Inc.
AGREEMENTSchedule 13d Agreement • April 23rd, 2004 • HRPT Properties Trust • Real estate investment trusts
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Hallwood Realty Partners, L.P., a Delaware limited partnership (the “Partnership”), or any subsequent acquisitions or dispositions of equity securities of the Partnership by the undersigned.
AGREEMENTSchedule 13d Agreement • March 9th, 2020 • Frazier Life Sciences IX, L.P. • Biological products, (no disgnostic substances)
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.
AGREEMENTSchedule 13d Agreement • November 2nd, 2012 • Atlas Venture Fund VII L P • In vitro & in vivo diagnostic substances
Pursuant to Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, each of the undersigned hereby agrees that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of common stock of ARCA biopharma, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.
AGREEMENTSchedule 13d Agreement • February 5th, 2015 • Children's Hospital of Philadelphia Foundation • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-l(k)(l) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Spark Therapeutics, Inc.
AGREEMENTSchedule 13d Agreement • November 21st, 2008 • Growth Equity Opportunities Fund, LLC • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of ARYx Therapeutics, Inc.
AGREEMENTSchedule 13d Agreement • October 11th, 2002 • Comdisco Holding Co Inc • Services-computer rental & leasing
The undersigned persons hereby agree that reports on Schedule 13D, and any amendments thereto, may be filed in a single statement on behalf of all such persons, and further, each such person designates Marc D. Hamburg as its agent and attorney-in-fact for the purpose of executing any and all such reports required to be made by it with the Securities and Exchange Commission.
AGREEMENTSchedule 13d Agreement • June 5th, 2013 • Baker Julian • Services-medical laboratories
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.0001 par value, of Genomic Health, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • May 14th, 2013 • Baker Julian • Services-medical laboratories
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.0001 par value, of Genomic Health, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • July 2nd, 2015 • Riverside Renewable Energy Investments, LLC • Construction - special trade contractors
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Class A Common Stock of Real Goods Solar, Inc.
AGREEMENTSchedule 13d Agreement • June 2nd, 2009 • Baker Julian • Biological products, (no disgnostic substances)
AGREEMENTSchedule 13d Agreement • May 27th, 2003 • Evergreen Solar Inc • Semiconductors & related devices
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Evergreen Solar, Inc.
AGREEMENTSchedule 13d Agreement • January 12th, 2012 • Riverside Renewable Energy Investments, LLC • Heating equipment, except electric & warm air furnaces
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Class A Common Stock of Real Goods Solar, Inc.
AGREEMENT The undersigned agree as follows: (1) Each of them is individually eligible to use the Schedule 13D to which this Agreement is attached, and such Schedule 13D is filed on behalf of each of them; (2) Each of them is responsible for the timely...Schedule 13d Agreement • February 7th, 2000 • Forren John • Services-management consulting services
AGREEMENTSchedule 13d Agreement • February 7th, 2020 • Frazier Life Sciences VIII, L.P. • Pharmaceutical preparations
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.
AGREEMENTSchedule 13d Agreement • May 20th, 2004 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, par value $.001 per share, of IntraBiotics Pharmaceuticals, Inc., and such other amendments as may be filed by them hereafter, are being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • April 18th, 2016 • Ebrahimi Farhad Fred • Agricultural production-crops
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Class A Units of Royal Hawaiian Orchards, LP.
AGREEMENTSchedule 13d Agreement • January 24th, 2005 • Goff Moore Strategic Partners L P • Fire, marine & casualty insurance
The undersigned reporting persons hereby agree that the statements filed pursuant to this Schedule 13D, to which this Agreement is filed as an exhibit, are filed on behalf of each of them.
AGREEMENTSchedule 13d Agreement • November 3rd, 2016 • Frazier Healthcare V, LP • Pharmaceutical preparations
This Schedule 13D was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which is attached as Exhibit 2.
AGREEMENTSchedule 13d Agreement • July 1st, 2003 • Analysts International Corp • Services-computer programming services
This will confirm the agreement by and among all the undersigned that the Schedule 13D filed on or about this date with respect to the beneficial ownership of the undersigned of shares of Common Stock of Analysts International Corporation is being filed on behalf of each of the entities names below. This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
AGREEMENTSchedule 13d Agreement • April 27th, 2023 • Ebrahimi Farhad Fred • Electromedical & electrotherapeutic apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of First Solar, Inc.
AGREEMENTSchedule 13d Agreement • August 8th, 2007 • Baker Julian • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.01 par value, of Biocryst Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
ContractSchedule 13d Agreement • April 18th, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Targeted Genetics Corporation.
AGREEMENTSchedule 13d Agreement • July 21st, 2021 • Frazier Healthcare VII, L.P. • Pharmaceutical preparations
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.
